X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs GSK PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA GSK PHARMA SANOFI INDIA/
GSK PHARMA
 
P/E (TTM) x 32.6 55.4 58.8% View Chart
P/BV x 6.5 9.9 66.0% View Chart
Dividend Yield % 1.4 1.3 108.0%  

Financials

 SANOFI INDIA   GSK PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
GSK PHARMA
Mar-17
SANOFI INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs4,5603,838 118.8%   
Low Rs4,4002,637 166.9%   
Sales per share (Unadj.) Rs1,028.5354.2 290.4%  
Earnings per share (Unadj.) Rs129.039.8 324.3%  
Cash flow per share (Unadj.) Rs186.042.9 433.8%  
Dividends per share (Unadj.) Rs68.0030.00 226.7%  
Dividend yield (eoy) %1.50.9 163.8%  
Book value per share (Unadj.) Rs753.6236.9 318.1%  
Shares outstanding (eoy) m23.0384.70 27.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.49.1 47.7%   
Avg P/E ratio x34.781.4 42.7%  
P/CF ratio (eoy) x24.175.5 31.9%  
Price / Book Value ratio x5.913.7 43.5%  
Dividend payout %52.775.4 69.9%   
Avg Mkt Cap Rs m103,174274,216 37.6%   
No. of employees `0003.64.7 77.1%   
Total wages/salary Rs m3,5924,830 74.4%   
Avg. sales/employee Rs Th6,537.76,387.0 102.4%   
Avg. wages/employee Rs Th991.41,028.3 96.4%   
Avg. net profit/employee Rs Th819.8717.1 114.3%   
INCOME DATA
Net Sales Rs m23,68630,000 79.0%  
Other income Rs m708728 97.2%   
Total revenues Rs m24,39430,728 79.4%   
Gross profit Rs m5,2814,190 126.0%  
Depreciation Rs m1,313263 499.2%   
Interest Rs m150-   
Profit before tax Rs m4,6614,655 100.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m1,6911,744 97.0%   
Profit after tax Rs m2,9703,368 88.2%  
Gross profit margin %22.314.0 159.6%  
Effective tax rate %36.337.5 96.8%   
Net profit margin %12.511.2 111.7%  
BALANCE SHEET DATA
Current assets Rs m15,67316,742 93.6%   
Current liabilities Rs m6,6787,202 92.7%   
Net working cap to sales %38.031.8 119.4%  
Current ratio x2.32.3 101.0%  
Inventory Days Days7652 146.7%  
Debtors Days Days2221 107.4%  
Net fixed assets Rs m8,0988,635 93.8%   
Share capital Rs m230847 27.2%   
"Free" reserves Rs m17,08819,222 88.9%   
Net worth Rs m17,35620,069 86.5%   
Long term debt Rs m010 0.0%   
Total assets Rs m25,40030,038 84.6%  
Interest coverage x311.7NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.91.0 93.4%   
Return on assets %11.811.2 104.8%  
Return on equity %17.116.8 102.0%  
Return on capital %26.925.5 105.8%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,145528 1,353.2%   
Fx outflow Rs m6,8467,193 95.2%   
Net fx Rs m299-6,665 -4.5%   
CASH FLOW
From Operations Rs m3,2262,360 136.7%  
From Investments Rs m-1,5553,008 -51.7%  
From Financial Activity Rs m-1,818-5,108 35.6%  
Net Cashflow Rs m-147260 -56.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 50.7 119.1%  
Indian inst/Mut Fund % 14.4 10.2 141.2%  
FIIs % 14.6 23.8 61.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 15.4 68.2%  
Shareholders   15,184 102,036 14.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 25, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - ASTRAZENECA PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS